Allurion Technologies (ALUR) Operating Margin (2022 - 2026)
Allurion Technologies (ALUR) posted Operating Margin of 126.6% for Q1 2026, up 26.9% on a QoQ basis from 173.18% in Q4 2025, and up 390.0% year-over-year from 25.84% in Q1 2025.
Allurion Technologies (ALUR) Operating Margin (2022 - 2026) Analysis & Trends
Allurion Technologies' Operating Margin history runs 5 years deep, the most recent figure standing at 126.6% for Q1 2026.
- Quarterly Operating Margin rose 390.0% year-over-year to 126.6% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 210.92% (down 4811.0% YoY) and the FY2025 annual result came in at 198.01%, down 4168.0% from the prior year.
- Operating Margin was 126.6% for Q1 2026 at Allurion Technologies, up from 173.18% in the prior quarter.
- Across five years, Operating Margin topped out at 26.42% in Q2 2022 and bottomed at 362.3% in Q3 2025.
- A 5-year average of 159.17% and a median of 128.55% in 2026 frame the typical range for Operating Margin.
- Annual changes were most pronounced in 2023 — Operating Margin slumped 25965 bps — and 2025, when it soared 13294 bps.
- Allurion Technologies' Operating Margin stood at 52.9% in 2022, then plunged by 491 bps to 312.54% in 2023, then climbed by 2 bps to 306.12% in 2024, then jumped by 43 bps to 173.18% in 2025, then gained by 27 bps to 126.6% in 2026.
- Business Quant data shows ALUR's Operating Margin at 126.6% in Q1 2026, 173.18% in Q4 2025, and 362.3% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | -126.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -126.60% |
| Dec 31, 2025 | -173.18% |
| Sep 30, 2025 | -362.30% |
| Jun 30, 2025 | -205.74% |
| Mar 31, 2025 | -130.50% |
| Dec 31, 2024 | -306.12% |
| Sep 30, 2024 | -229.94% |
| Jun 30, 2024 | -79.43% |
| Mar 31, 2024 | -121.35% |
| Dec 31, 2023 | -312.54% |
| Sep 30, 2023 | -143.70% |
| Jun 30, 2023 | -102.58% |
| Mar 31, 2023 | -98.78% |
| Dec 31, 2022 | -52.90% |
| Sep 30, 2022 | -74.61% |
| Jun 30, 2022 | -26.42% |